Final Programme - World Heart Federation

Decompensated Heart Failure
Faculty
Nadine Clausell, MD, PhD (Co-Chair)
Associate Professor of Medicine
Federal University of Rio Grande do Sul
Porto Alegre, RS, Brazil
Sergio V. Perrone, MD (Co-Chair)
Medical Director —
Intrathoracic Transplant & Heart Failure Division
FLENI Institute
Buenos Aires, Argentina
Uri Elkayam, MD
Professor of Medicine
University of Southern California,
Keck School of Medicine
Los Angeles, California
J. Thomas Heywood, MD, FACC
Clinical Professor of Medicine
Loma Linda University School of Medicine
Loma Linda, California
Fábio Vilas-Boas, MD, PhD
Chief Cardiology Division
Hospital Espanhol
Salvador, BA, Brazil
Agenda
17:30 – 18:00 Reception
18:00 – 18:05 Introduction (Co-chairs)
Nadine Clausell, MD, PhD
Sergio Perrone, MD
Programme Overview
Organized by
Acute decompensated heart failure (ADHF) is associated with
prolonged in-hospital lengths of stay, high rates of hospital
readmission, and substantial rates of inpatient and outpatient
morbidity and mortality. In Latin American countries, the incidence of
heart failure is rising, and ADHF has not been as well characterized as
chronic heart failure. An awareness of unmet needs in ADHF
management is therefore useful to improve the process of care in this
patient population. Goals of therapy for ADHF include relieving
symptoms, reversing acute hemodynamic abnormalities, initiating
evidence-based therapy, reducing length of stay, and preventing
rehospitalization. Treatment recommendations are generally based on
the patient’s fluid volume status and cardiac output. It is therefore
critical for cardiologists to be aware of when to use various intravenous
therapies for improving hemodynamics and acute heart failure signs
and symptoms. One such agent is the vasodilator nesiritide, a purified
preparation of human B-type natriuretic peptide (hBNP), which
reduces pulmonary capillary wedge pressure and improves dyspnea in
patients with ADHF who have dyspnea at rest or with minimal activity.
This program will help Latin American cardiologists understand the
challenges in managing ADHF and effective therapeutic strategies for
treating patients with different hemodynamic and clinical profiles. In
addition, faculty members will describe and demonstrate through case
presentation the appropriate use of nesiritide in patients with ADHF.
18:05 – 18:15 Focus on Latin America:
Unmet Needs in Acute Decompensated Heart Failure Management
Nadine Clausell, MD, PhD
18:15 – 18:35 Current Treatment Options for Acute Decompensated Heart Failure
Uri Elkayam, MD
18:35 – 18:55 Nesiritide Therapy for the ADHF Patient
J. Thomas Heywood, MD
18:55 – 19:15 Case Presentation and Panel Discussion
Moderator: Uri Elkayam, MD
Panelists: Nadine Clausell, MD, PhD, Sergio Perrone, MD, Fábio Vilas-Boas, MD, PhD,
J. Thomas Heywood, MD
19:15 – 19:30 Question and Answer